<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Reason For Referral</a></li><li><a href="#id3">REASON FOR VISIT</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Social History</a></li><li><a href="#id6">Vital Signs</a></li><li><a href="#id7">Encounters</a></li><li><a href="#id8">Assessments</a></li><li><a href="#id9">Plan Of Treatment</a></li><li><a href="#id10">Progress Notes</a></li><li><a href="#id11">History and Physical Notes</a></li><li><a href="#id12">Consultation Request Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>Routine skin exam</td></tr><tr><th>Diagnosis 1</th><td>Skin cancer screening (Z12.83)</td></tr><tr><th>Referral Organization</th><td>[REDACTED] MD PLC</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED] MD, [REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Dermatology</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr></tbody></table></div><h3><a name="id3" href="#toc">REASON FOR VISIT</a></h3><div>Comprehensive Evaluation</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Metoprolol Succinate ER 200 MG</td><td ID="instruction1">sig 1 tab BID Oral</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Eplerenone 50 MG</td><td ID="instruction2">sig 1 tab bid Oral</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">QUEtiapine Fumarate 50 MG</td><td ID="instruction3">1 tablet at bedtime Orally bedtime for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication4">Lovastatin 40 MG</td><td ID="instruction4">sig 1 tab qhs for hypercholesterolemia Oral</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Famotidine 20 MG</td><td ID="instruction5">sig 1 tab Orally bedtime for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication6">Auto-CPAP at 4-20 cm/H20 pressure</td><td ID="instruction6">us as directed externally for 99 days</td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication7">Famotidine 20 MG</td><td ID="instruction7">sig 1 tab Orally twice per day on empty stomach for 14 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication8">Bicalutamide 50 MG</td><td ID="instruction8">1 tablet Oral Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Docusate Sodium 100 MG</td><td ID="instruction9">TAKE ONE CAPSULE BY MOUTH TWICE A DAY AS NEEDED FOR CONSTIPATION Oral for 30</td><td/><td/><td/><td>Not-Taking</td></tr><tr><td ID="medication10">Spironolactone 50 MG</td><td ID="instruction10">TAKE ONE TABLET BY MOUTH ONE TIME DAILY for 30</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Clotrimazole-Betamethasone 1-0.05 %</td><td ID="instruction11">sig apply to affected area Externally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">Donepezil HCl 5 MG</td><td ID="instruction12">1 tablet at bedtime Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication13">Omeprazole 40 MG</td><td ID="instruction13">1 capsule Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication14">Terazosin HCl 10 MG</td><td ID="instruction14">sig 1 tab daily Oral</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table></div><h3><a name="id6" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Blood pressure systolic</th><td>122 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Blood pressure diastolic</th><td>74 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Heart Rate</th><td>66 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Height</th><td>69 in</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Weight</th><td>242 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital6">BMI</th><td>35.73 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital7">Oximetry</th><td>96 %</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>[REDACTED] MD PLC</td><td>[REDACTED][REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Recurrent prostate cancer C61 ; Other chronic pulmonary embolism without acute cor pulmonale I27.82 ; Coagulation defect D68.9 ; Thrombocytopenia, unspecified D69.6 ; Atherosclerosis of aorta I70.0 ; Mixed hyperlipidemia E78.2 ; Chronic diastolic (congestive) heart failure I50.32 ; Erectile dysfunction due to arterial insufficiency N52.01 ; Morbid (severe) obesity due to excess calories E66.01 ; BMI 35.0-35.9,adult Z68.35 ; Physical exam Z00.00 ; Hypertensive heart disease without heart failure I11.9 ; Impaired fasting glucose R73.01 ; Obstructive sleep apnea (adult) (pediatric) G47.33 ; Cortical age-related cataract, unspecified eye H25.019 ; BPH w/o urinary obs/LUTS N40.0 ; DDD (degenerative disc disease), cervical M50.30 ; GERD without esophagitis K21.9 ; Epiretinal membrane, left eye H35.372 ; Urinary urgency R39.15 ; Dermatitis L30.9 ; Unilateral primary osteoarthritis, right knee M17.11 ; Bacteriuria R82.71 ; Klebsiella pneumoniae infection A49.8 ; Exposure to COVID-19 virus Z20.822 ; Intrinsic sphincter deficiency (ISD) N36.42 ; Unspecified urinary incontinence R32 ; Synovial cyst of right knee M71.21 ; Hypoglycemia E16.2 ; Mild cognitive impairment G31.84 ; Mature cataract H26.8 ; Vitamin D deficiency E55.9 and Thyroid disorder screen Z13.29</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Recurrent prostate cancer (ICD-10 - C61)</td><td><p>PSA rose to 1.73 Quest [REDACTED] from 1.32 Quest [REDACTED] from 0.72 Quest [REDACTED] from 0.7 ng/mL [REDACTED] to 1.4ng/mL Quest [REDACTED] &amp; Quest [REDACTED] up to 1.9 ng/mlQuest [REDACTED]. PSA rose to 2.1 ng/ml on Quest [REDACTED] &amp; [REDACTED] from 1.9 ng/ml on [REDACTED]. PSA dropped to 0.11 on [REDACTED], rose to 0.12 on [REDACTED] and 0.17 [REDACTED] Quest to 0.52 Quest [REDACTED] to 0.72 Quest [REDACTED]</p><p>prostate biopsy 02.2021 that revealed four quadrants with [REDACTED] 9 and one quadrant [REDACTED] 7 prostate adenocarcinoma</p></td><td/><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>Other chronic pulmonary embolism without acute cor pulmonale (ICD-10 - I27.82)</td><td>chronic pulmonary emboli RLL on CTA chest [REDACTED] Gateway. bilateral [REDACTED] &amp; subsegmental pulmonary emboli of all lobes on CTA chest Gateway Radiology [REDACTED]. chronic pulmonary emboli resolved on CTA [REDACTED] Simon Med</td><td/><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Coagulation defect (ICD-10 - D68.9)</td><td/><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Thrombocytopenia, unspecified (ICD-10 - D69.6)</td><td>thrombocytopenia 115 th/uL (140-400) Quest up from 110 th/uL (140-400) Quest [REDACTED], down from 113 th/uL (140-400) Quest [REDACTED] down from 115 th/uL (140-400) Quest [REDACTED] up from 99 Thousand/uL (140-400) Quest [REDACTED] down from 124 Quest [REDACTED] up from 105 Thousand/uL (140-400) on [REDACTED] Quest down from 111 (150-379) on [REDACTED] @ Labcorp</td><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Atherosclerosis of aorta (ICD-10 - I70.0)</td><td>aortic atherosclerosis on CAT chest [REDACTED] @ WestCoast Radiology</td><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td/><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Chronic diastolic (congestive) heart failure (ICD-10 - I50.32)</td><td/><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Erectile dysfunction due to arterial insufficiency (ICD-10 - N52.01)</td><td/><td/><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Morbid (severe) obesity due to excess calories (ICD-10 - E66.01)</td><td/><td/><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>BMI 35.0-35.9,adult (ICD-10 - Z68.35)</td><td/><td/><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Physical exam (ICD-10 - Z00.00)</td><td/><td/><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Hypertensive heart disease without heart failure (ICD-10 - I11.9)</td><td/><td/><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>Impaired fasting glucose (ICD-10 - R73.01)</td><td>reduce intake of carbohydrate rich foods. Written instruction material provided.</td><td/><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>Obstructive sleep apnea (adult) (pediatric) (ICD-10 - G47.33)</td><td/><td/><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>Cortical age-related cataract, unspecified eye (ICD-10 - H25.019)</td><td/><td/><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>BPH w/o urinary obs/LUTS (ICD-10 - N40.0)</td><td/><td/><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>DDD (degenerative disc disease), cervical (ICD-10 - M50.30)</td><td/><td/><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>GERD without esophagitis (ICD-10 - K21.9)</td><td/><td/><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>Epiretinal membrane, left eye (ICD-10 - H35.372)</td><td/><td/><td/></tr><tr><td ID="ref20">[REDACTED]</td><td>Urinary urgency (ICD-10 - R39.15)</td><td/><td/><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>Dermatitis (ICD-10 - L30.9)</td><td/><td/><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>Unilateral primary osteoarthritis, right knee (ICD-10 - M17.11)</td><td/><td/><td/></tr><tr><td ID="ref23">[REDACTED]</td><td>Bacteriuria (ICD-10 - R82.71)</td><td/><td/><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>Klebsiella pneumoniae infection (ICD-10 - A49.8)</td><td/><td/><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>Exposure to COVID-19 virus (ICD-10 - Z20.822)</td><td/><td/><td/></tr><tr><td ID="ref26">[REDACTED]</td><td>Intrinsic sphincter deficiency (ISD) (ICD-10 - N36.42)</td><td/><td/><td/></tr><tr><td ID="ref27">[REDACTED]</td><td>Unspecified urinary incontinence (ICD-10 - R32)</td><td/><td/><td/></tr><tr><td ID="ref28">[REDACTED]</td><td>Synovial cyst of right knee (ICD-10 - M71.21)</td><td/><td/><td/></tr><tr><td ID="ref29">[REDACTED]</td><td>Hypoglycemia (ICD-10 - E16.2)</td><td/><td/><td/></tr><tr><td ID="ref30">[REDACTED]</td><td>Mild cognitive impairment (ICD-10 - G31.84)</td><td>MMSE 26/30 c/w MCI</td><td/><td/></tr><tr><td ID="ref31">[REDACTED]</td><td>Mature cataract (ICD-10 - H26.8)</td><td/><td/><td/></tr><tr><td ID="ref32">[REDACTED]</td><td>Vitamin D deficiency (ICD-10 - E55.9)</td><td/><td/><td/></tr><tr><td ID="ref33">[REDACTED]</td><td>Thyroid disorder screen (ICD-10 - Z13.29)</td><td/><td/><td/></tr><tr><td ID="ref34">[REDACTED]</td><td>Other</td><td/><td>Follow up with Dr. Laryngakis scheduled 10.2024Discussed importance of treatment of CPAP- continues to refuseDiscussed importance of increasing physical activity </td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">QUEtiapine Fumarate 50 MG</td><td>1 tablet at bedtime Orally bedtime for 30 days</td><td>[REDACTED]</td><td/><td/></tr><tr><td ID="potMeds2">Famotidine 20 MG</td><td>sig 1 tab Orally bedtime for 90 days</td><td>[REDACTED]</td><td/><td/></tr><tr><td ID="potMeds3">QUEtiapine Fumarate 25 MG</td><td>1 tablet at bedtime Orally bedtime</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Other</td><td>Follow up with Dr. Laryngakis scheduled 10.2024Discussed importance of treatment of CPAP- continues to refuseDiscussed importance of increasing physical activity </td></tr></tbody></table><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">LIPID PANEL</td><td>[REDACTED]</td></tr><tr><td ID="futureTest2">COMPREHENSIVE METABOLIC PANEL</td><td>[REDACTED]</td></tr><tr><td ID="futureTest3">CBC (INCLUDES DIFF/PLT)</td><td>[REDACTED]</td></tr><tr><td ID="futureTest4">URINALYSIS, COMPLETE W/REFLEX TO CULTURE</td><td>[REDACTED]</td></tr><tr><td ID="futureTest5">HEMOGLOBIN A1c</td><td>[REDACTED]</td></tr><tr><td ID="futureTest6">TSH W/REFLEX TO FT4</td><td>[REDACTED]</td></tr><tr><td ID="futureTest7">VITAMIN D,25-OH,TOTAL,IA</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Referrals</span><table width="100%" border="1"><thead><tr><th>Referral Date</th><th>Details</th></tr></thead><tbody><tr><td ID="referral1">[REDACTED]</td><td>[REDACTED], Routine skin exam, [REDACTED] MD</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 4 Months, Reason: MWE w/ lab review</td></tr><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 10:00:00 AM, [REDACTED][REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id10" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 31041 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Office Visit</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>31041</td><td align="right"><span class="bold">Provider: </span>[REDACTED], DNP, ARNP-C</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>78 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>[REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   Comprehensive Evaluation</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Patient Care Team</span>: <br/>      Dermatologist: [REDACTED] PA-C, Address; [REDACTED] Phone [REDACTED]. <br/>      Ophthalmologist: [REDACTED], [REDACTED], Address:  [REDACTED] Phone [REDACTED]. <br/>      Urologist: [REDACTED] MD urologist.Phone: [REDACTED] Address: [REDACTED]. <br/>   <span class="Underline">Interim History</span>: <br/>       This [REDACTED] White Male presents for  follow up on chronic conditions including lab review. <br/>He completed a fractionated course of radiation therapy for prostate cancer in [REDACTED].  He continues in surveillance of recurrent prostate cancer with microscopic spread.  PSA rose from 0.7 ng/mL [REDACTED] to 1.4ng/mL Quest [REDACTED] &amp; Quest [REDACTED]  up to 1.9 ng/mlQuest [REDACTED].  PSA rose to 2.1 ng/ml on Quest [REDACTED] &amp; [REDACTED] from 1.9 ng/ml on [REDACTED].  He continues on terazosin for associated hypertrophy.  He denies dysuria, hematuria, discharge, urinary frequency, urinary hesitancy, nocturia, incontinence, genital sores and decreased libido. He saw [REDACTED] MD who recommended observation. He saw urologist [REDACTED] MD [REDACTED] who ordered prostate biopsy [REDACTED] that revealed four quadrants with [REDACTED] 9 and one quadrant [REDACTED] 7 prostate adenocarcinoma. He saw the urologist [REDACTED] MD on [REDACTED] @ USF who performed radical prostatectomy and mentioned the possible complications which include but not limited to ED, incontinence, rectal/bowel injury, infection, bleeding, transfusion, MI, CVA, lymphocele, positional injury, PE, DVT, death, anastomotic stricture or leak, rectal injury, permanent colostomy, secondary therapy and death.  I reviewed these complications and risks with patient.  Patient had postoperative complications of DVT, PE and urinary incontinence which has persisted. He completed a course of pelvic therapy with TENS unit for urinary incontinence with modest results. His PSA has risen postoperatively from 0.17 Quest [REDACTED] to 0.26 Quest [REDACTED] to 0.51 Quest [REDACTED] to 0.52 Quest [REDACTED] to 0.72 Quest [REDACTED] to 1.73 Quest [REDACTED] and 2.80 Quest [REDACTED] and up to 3.24 Quest [REDACTED].  He just completed a 10 day course of amoxicillin/clavulanic acid for Klebsiella UTI. He continues on bicalutamide therapy. He started Lupron every three months on [REDACTED].<br/>After CTA [REDACTED] [REDACTED] revealed resolution of chronic pulmonary emboli, he stopped warfarin anticoagulation. Origininally , he had findings of bilateral lobar &amp; subsegmental pulmonary emboli of all lobes on CTA chest Gateway Radiology [REDACTED]. He had findings of chronic pulmonary emboli RLL on CTA chest [REDACTED] Gateway.  Patient denies chest pain, dyspnea and bleeding.<br/>  He continues in surveillance of thrombocytopenia 115 th/uL (140-400) Quest up from 110 th/uL (140-400) Quest [REDACTED], down from 113 th/uL (140-400) Quest [REDACTED] down from  115 th/uL (140-400) Quest [REDACTED] up from 99 Thousand/uL (140-400) Quest [REDACTED] down from 124 Quest [REDACTED] up from 105 Thousand/uL (140-400) on [REDACTED] Quest down from 111 (150-379) on [REDACTED] @ Labcorp.  He denies intercurrent infections or bleeding. <br/> He continues in surveillance of aortic atherosclerosis on CAT chest [REDACTED] @ WestCoast Radiology.<br/>  He continues on metoprolol and eplerenone therapy for hypertension and secondary chronic diastolic CHF on echocardiogram [REDACTED] @ Clearwater Cardiovascular Consultants. Patient denies chest pain, cough, sore throat, headache. He underwent myocardial perfusion imaging stress testing due to ST/T changes on EKG with benign findings on [REDACTED]. He reports intermittent dyspnea due to morbid obesity after bending over or walking briskly. Due to bilateral lower extremity edema, he underwent bilateral venous LE doppler study [REDACTED] Gateway that revealed absence of DVT but presence of right popliteal cyst 57 x 17 x 29 mm.<br/>He continues on sildenafil phosphodiesterase inhibitor therapy for erectile dysfunction due to arterial insufficiency.  Patient has noted moderate improvement on this regimen.   <br/>He continues on lovastatin therapy for mixed hyperlipidemia.  Patient denies any myalgias.<br/> He continues on a low carbohydrate diet with exercise in treating impaired fasting glucose. <br/> Patient declines proceeding with colonoscopy  examination in spite of the risk of undetected colorectal neoplasm and the subsequent morbidity and mortality.  Patient denies nausea, vomiting, abdominal pain, melena, hematochezia, diarrhea, constipation or jaundice.  His FIT testing [REDACTED] was negative. <br/> He continues in surveillance of of left epiretinal membrane by the retinal ophthalmologist Faysesal El Jaball DO.<br/> He received treatment for obstructive sleep apnea with CPAP machine and mask which he stopped due to discomfort. <br/> He reports pain of the vertebral prominens when he extends his head backwards looking up to the ceiling.<br/>   He has visually significant cataracts necessitating intervention.<br/>He continues on donepezil therapy for mild cognitive impairment.  He has MMSE 26/30. Due to visual hallucinations of seeing children playing, he received Rx for quetiapine.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General/Constitutional</span>: <br/>      Comments <span class="bold">See HPI for details</span>.   <br/>   <span class="Underline">Endocrine</span>: <br/>      Comments See HPI for details.   <br/>   <span class="Underline">Respiratory</span>: <br/>      Comments <span class="bold">See HPI for details</span>.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Comments <span class="bold">See HPI for details</span>.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Comments <span class="bold">See HPI for details</span>.   <br/>   <span class="Underline">Hematology</span>: <br/>      Comments See HPI for details.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      Urinary incontinence denies. Comments <span class="bold">See HPI for details</span>.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      Comments <span class="bold">See HPI for details</span>.   <br/>   <span class="Underline">Neurologic</span>: <br/>      Falls denies.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> radiation therapy prostate 2013-4 11/29/2016radical prostectomy 6/2021IOL OU 6.2024</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> Radical prostectomy 06/21</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: deceased [REDACTED] yrs. Mother: deceased [REDACTED] yrs, lung cancer,  diagnosed with Cancer. <br/>father deceased age [REDACTED]- natural causes<br/>mother deceased age [REDACTED]- lung cancer<br/>2 brothers &amp; 1 sister well: colon polyps (brother)<br/>1 son [REDACTED] well,.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   never smoked<br/>      alcohol- 7-8 drinks per week previously, rare use since [REDACTED] pandemic<br/>      married 55 years [REDACTED]<br/>      retired construction worker.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingMetoprolol Succinate ER 200 MG XR24H-TAB sig 1 tab BID Oral  Eplerenone 50 MG TABS sig 1 tab bid Oral  Lovastatin 40 MG TABS sig 1 tab qhs for hypercholesterolemia Oral  Omeprazole 40 MG Capsule Delayed Release 1 capsule Orally Once a day Terazosin HCl 10 MG CAPS sig 1 tab daily Oral  Clotrimazole-Betamethasone 1-0.05 % Cream sig apply to affected area Externally Twice a day Donepezil HCl 5 MG Tablet 1 tablet at bedtime Orally Once a day QUEtiapine Fumarate 25 MG Tablet 1 tablet at bedtime Orally bedtime Spironolactone 50 MG Tablet TAKE ONE TABLET BY MOUTH ONE TIME DAILY   Famotidine 20 MG Tablet sig 1 tab Orally twice per day on empty stomach Bicalutamide 50 MG Tablet 1 tablet Oral Once a day Taking Metoprolol Succinate ER 200 MG XR24H-TAB sig 1 tab BID Oral  Taking Eplerenone 50 MG TABS sig 1 tab bid Oral  Taking Lovastatin 40 MG TABS sig 1 tab qhs for hypercholesterolemia Oral  Taking Omeprazole 40 MG Capsule Delayed Release 1 capsule Orally Once a day Taking Terazosin HCl 10 MG CAPS sig 1 tab daily Oral  Taking Clotrimazole-Betamethasone 1-0.05 % Cream sig apply to affected area Externally Twice a day Taking Donepezil HCl 5 MG Tablet 1 tablet at bedtime Orally Once a day Taking QUEtiapine Fumarate 25 MG Tablet 1 tablet at bedtime Orally bedtime Taking Spironolactone 50 MG Tablet TAKE ONE TABLET BY MOUTH ONE TIME DAILY   Taking Famotidine 20 MG Tablet sig 1 tab Orally twice per day on empty stomach Taking Bicalutamide 50 MG Tablet 1 tablet Oral Once a day Not-TakingAuto-CPAP at 4-20 cm/H20 pressure   us as directed externally  Docusate Sodium 100 MG Capsule TAKE ONE CAPSULE BY MOUTH TWICE A DAY AS NEEDED FOR CONSTIPATION Oral  Medication List reviewed and reconciled with the patientNot-Taking Auto-CPAP at 4-20 cm/H20 pressure   us as directed externally  Not-Taking Docusate Sodium 100 MG Capsule TAKE ONE CAPSULE BY MOUTH TWICE A DAY AS NEEDED FOR CONSTIPATION Oral  Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> HR: 66 /min, BP: 122/74 mm Hg, Wt: 242 lbs, BMI: 35.73 Index, Ht: 69 in, Oxygen sat %: 96 %.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      GENERAL APPEARANCE: well nourished, well hydrated, in no acute distress. <br/>      HEAD: normocephalic, atraumatic. <br/>      EYES: sclera anicteric.  , conjunctiva clear. . <br/>      NECK/THYROID: neck supple, full range of motion, no carotid bruit, trachea midline , no thyroid nodules or neck mass. <br/>      SKIN: pigmented lesion nose. white pigmentation dorsal feet. xerosis feet. <br/>      HEART: regular rate and rhythm, S1, S2 normal, no murmurs or gallops. <br/>      LUNGS: no wheezes, rales, rhonchi. <br/>      CHEST: clear to auscultation bilaterally. <br/>      MUSCULOSKELETAL: full range of motion. <br/>      EXTREMITIES: no clubbing, cyanosis, or edema. <br/>      PSYCH: alert, oriented , judgement and insight good , mood/affect full range.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Recurrent prostate cancer - C61 (Primary)   <content><span class="bold">Notes : </span>PSA rose to 1.73 Quest [REDACTED] from 1.32 Quest [REDACTED] from 0.72 Quest [REDACTED] from 0.7 ng/mL [REDACTED] to 1.4ng/mL Quest [REDACTED] &amp; Quest [REDACTED] up to 1.9 ng/mlQuest [REDACTED]. PSA rose to 2.1 ng/ml on Quest [REDACTED] &amp; [REDACTED] from 1.9 ng/ml on [REDACTED]. PSA dropped to 0.11 on [REDACTED], rose to 0.12 on [REDACTED] and 0.17 [REDACTED] Quest to 0.52 Quest [REDACTED] to 0.72 Quest 7.3.2023prostate biopsy 02.2021 that revealed four quadrants with [REDACTED] 9 and one quadrant [REDACTED] 7 prostate adenocarcinoma</content>   2. Other chronic pulmonary embolism without acute cor pulmonale - I27.82   <content><span class="bold">Notes : </span>chronic pulmonary emboli RLL on CTA chest [REDACTED] Gateway. bilateral [REDACTED] &amp; subsegmental pulmonary emboli of all lobes on CTA chest Gateway Radiology [REDACTED]. chronic pulmonary emboli resolved on CTA [REDACTED] Simon Med</content>   3. Coagulation defect - D68.9   4. Thrombocytopenia, unspecified - D69.6   <content><span class="bold">Notes : </span>thrombocytopenia 115 th/uL (140-400) Quest up from 110 th/uL (140-400) Quest [REDACTED], down from 113 th/uL (140-400) Quest [REDACTED] down from 115 th/uL (140-400) Quest [REDACTED] up from 99 Thousand/uL (140-400) Quest [REDACTED] down from 124 Quest [REDACTED] up from 105 Thousand/uL (140-400) on [REDACTED] Quest down from 111 (150-379) on [REDACTED] @ Labcorp</content>   5. Atherosclerosis of aorta - I70.0   <content><span class="bold">Notes : </span>aortic atherosclerosis on CAT chest [REDACTED] @ WestCoast Radiology</content>   6. Mixed hyperlipidemia - E78.2   7. Chronic diastolic (congestive) heart failure - I50.32   8. Erectile dysfunction due to arterial insufficiency - N52.01   9. Morbid (severe) obesity due to excess calories - E66.01   10. BMI 35.0-35.9,adult - Z68.35   11. Physical exam - Z00.00   12. Hypertensive heart disease without heart failure - I11.9   13. Impaired fasting glucose - R73.01   <content><span class="bold">Notes : </span>reduce intake of carbohydrate rich foods. Written instruction material provided.</content>   14. Obstructive sleep apnea (adult) (pediatric) - G47.33   15. Cortical age-related cataract, unspecified eye - H25.019   16. BPH w/o urinary obs/LUTS - N40.0   17. DDD (degenerative disc disease), cervical - M50.30   18. GERD without esophagitis - K21.9   19. Epiretinal membrane, left eye - H35.372   20. Urinary urgency - R39.15   21. Dermatitis - L30.9   22. Unilateral primary osteoarthritis, right knee - M17.11   23. Bacteriuria - R82.71   24. Klebsiella pneumoniae infection - A49.8   25. Exposure to COVID-19 virus - Z20.822   26. Intrinsic sphincter deficiency (ISD) - N36.42   27. Unspecified urinary incontinence - R32   28. Synovial cyst of right knee - M71.21   29. Hypoglycemia - E16.2   30. Mild cognitive impairment - G31.84   <content><span class="bold">Notes : </span>MMSE 26/30 c/w MCI</content>   31. Mature cataract - H26.8   32. Vitamin D deficiency - E55.9   33. Thyroid disorder screen - Z13.29   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Thrombocytopenia, unspecified</span> <br/>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (Ordered for [REDACTED])</span></td></tr><tr><td/></tr><tr><td><span class="bold">2. Mixed hyperlipidemia</span> <br/>     <span class="Underline">LAB: LIPID PANEL (Ordered for [REDACTED])</span><br/>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (Ordered for [REDACTED])</span></td></tr><tr><td/></tr><tr><td><span class="bold">3. Impaired fasting glucose</span> <br/>     <span class="Underline">LAB: HEMOGLOBIN A1c (Ordered for [REDACTED])</span></td></tr><tr><td/></tr><tr><td><span class="bold">4. GERD without esophagitis</span> <br/>Start Famotidine Tablet, 20 MG, sig 1 tab, Orally, bedtime, 90 days, 90 Tablet, Refills 1.  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Urinary urgency</span> <br/>     <span class="Underline">LAB: URINALYSIS, COMPLETE W/REFLEX TO CULTURE (Ordered for [REDACTED])</span></td></tr><tr><td/></tr><tr><td><span class="bold">6. Mild cognitive impairment</span> <br/>Stop QUEtiapine Fumarate Tablet, 25 MG, 1 tablet at bedtime, Orally, bedtime.  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Vitamin D deficiency</span> <br/>     <span class="Underline">LAB: VITAMIN D,25-OH,TOTAL,IA (Ordered for [REDACTED])</span></td></tr><tr><td/></tr><tr><td><span class="bold">8. Thyroid disorder screen</span> <br/>     <span class="Underline">LAB: TSH W/REFLEX TO FT4 (Ordered for [REDACTED])</span></td></tr><tr><td/></tr><tr><td><span class="bold">9. Others </span> <br/>Start QUEtiapine Fumarate Tablet, 50 MG, 1 tablet at bedtime, Orally, bedtime, 30 days, 90, Refills 3.  <br/>Notes: Follow up with Dr. Laryngakis scheduled 10.2024Discussed importance of treatment of CPAP- continues to refuseDiscussed importance of increasing physical activity           <br/> Referral To:[REDACTED] MD  Dermatology<br/>              Reason:Routine skin exam<br/></td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 1003F HEDIS Physical Activity Assessed1090F HEDIS Urinary Incontinence Assessed1158F HEDIS Living Will Document Discussion1157F HEDIS Living Will in Chart1101F HEDIS Fall Assessment w/o falls or injury past year1159F HEDIS Medication List Document1160F HEDIS Medication List ReviewG8427 HEDIS Medication List Update1126F HEDIS Pain Absent2022F HEDIS DM retinal exam by eye doctor past year3008F HEDIS BMI documented3044F HEDIS DM HbA1c &lt; 7.0%3048F HEDIS LDL &lt; 100 mg/dL3074F HEDIS SBP &lt; 130 mm Hg3078F HEDIS DBP &lt;80 mm Hg</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  Screenings: <br/>       FALL RISK SCREENING <br/>          Fall Risk Assessment: <span class="italics">No falls in the past year</span><br/>  Handouts Given: <br/>       Living Will Provide living will to patient at checkout. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 4 Months (Reason: MWE w/ lab review)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>1003F HEDIS Physical Activity Assessed. <br/>1090F HEDIS Urinary Incontinence Assessed. <br/>1158F HEDIS Living Will Document Discussion. <br/>1157F HEDIS Living Will in Chart. <br/>1101F HEDIS Fall Assessment w/o falls or injury past year. <br/>1159F HEDIS Medication List Document. <br/>1160F HEDIS Medication List Review. <br/>G8427 HEDIS Medication List Update. <br/>1126F HEDIS Pain Absent. <br/>2022F HEDIS DM retinal exam by eye doctor past year. <br/>3008F HEDIS BMI documented. <br/>3044F HEDIS DM HbA1c &lt; 7.0%. <br/>3048F HEDIS LDL &lt; 100 mg/dL. <br/>3074F HEDIS SBP &lt; 130 mm Hg. <br/>3078F HEDIS DBP &lt;80 mm Hg. </td></tr></tbody></table></li></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , DNP ARNP C  on [REDACTED] 09:34 AM EDT</td></tr><tr><td valign="top">Electronically co-signed by [REDACTED], MD MACP on [REDACTED] 12:24 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr><tr><td valign="top"><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td colspan="2"><span class="bold">Addendum:</span></td></tr><tr><td><ul><li><table border="0"><tbody><tr><td>[REDACTED] 12:24 AM [REDACTED] &gt; More than 50% of the 55 minute encounter time was devoted to discussion of the diagnostic impression, pathophysiologies, prognosis, management and therapeutic options, as well as discussion of the risk/benefit ratios of the anticipated therapies.Furthermore, the entire History of Present Illness, including the medical diagnoses and therapies were reviewed with the patient and re written in entirety without copying and pasting from prior clinical notes.I certify that the above documentation is true.I have discussed with the advanced registered nurse practitioner (ARNP) the history, physical, the diagnostic impression and treatment plan for the patient.  All medical decision-making was done by me.  Please see the ARNP note for more details.</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table cellpadding="0" cellspacing="0" width="100%" border="0"><tbody><tr><td> </td></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], DNP, ARNP-C</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 02:25 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id11" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="3">Patient Care Team</td><td>Dermatologist:</td><td colspan="2">[REDACTED] PA-C, Address; [REDACTED] Phone [REDACTED]</td></tr><tr><td>Ophthalmologist:</td><td colspan="2">[REDACTED], Address:  [REDACTED] Phone [REDACTED]</td></tr><tr><td>Urologist:</td><td colspan="2">[REDACTED] MD urologist.Phone: [REDACTED] Address: [REDACTED]</td></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="11">General Examination</td><td>GENERAL APPEARANCE:</td><td colspan="2">well nourished, well hydrated, in no acute distress</td></tr><tr><td>HEAD:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>EYES:</td><td colspan="2">sclera anicteric.  , conjunctiva clear.</td></tr><tr><td>NECK/THYROID:</td><td colspan="2">neck supple, full range of motion, no carotid bruit, trachea midline , no thyroid nodules or neck mass</td></tr><tr><td>HEART:</td><td colspan="2">regular rate and rhythm, S1, S2 normal, no murmurs or gallops</td></tr><tr><td>CHEST:</td><td colspan="2">clear to auscultation bilaterally</td></tr><tr><td>LUNGS:</td><td colspan="2">no wheezes, rales, rhonchi</td></tr><tr><td>SKIN:</td><td colspan="2">pigmented lesion nose. white pigmentation dorsal feet. xerosis feet</td></tr><tr><td>EXTREMITIES:</td><td colspan="2">no clubbing, cyanosis, or edema</td></tr><tr><td>MUSCULOSKELETAL:</td><td colspan="2">full range of motion</td></tr><tr><td>PSYCH:</td><td colspan="2">alert, oriented , judgement and insight good , mood/affect full range</td></tr></tbody></table><br/></li></ul></div><h3><a name="id12" href="#toc">Consultation Request Notes</a></h3><div><table width="100%" border="1"><tbody><tr><th>Referral Date</th><th>Referring Provider</th><th>Referred Provider</th><th>Notes</th></tr><tr ID="ConsultationNote1"><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED] MD, [REDACTED]</td><td>Routine skin exam</td></tr></tbody></table></div><br/><br/>
</body></html>